Home | Symbol Index | About |
Tue, 27 Jun 2006 11:56:00 PDT
SAN DIEGO, CA (MARKET WIRE) Cypress Bioscience Inc. (NASDAQ: CYPB) announced today that results of recently completed Phase IIa trials do not support continuing a development program evaluating combinations of mirtazapine with another approved drug as potential pharmaceutical treatments for obstructive sleep apnea (OSA).
Trackbacks
A trackback is a mechanism for communication between blogs. The following blog entries have been detected that are in reference to Cypress Bioscience: Pilot Trials in Obstructive Sleep Apnea Completed.
- No trackbacks have been detected.
What is a Stock Cloud?
A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.